KEEL vs. KPTI
KEEL (Keel Infrastructure Corporation) and KPTI (Karyopharm Therapeutics Inc.) are both stocks. KEEL operates in Capital Markets (Financial Services), while KPTI operates in Biotechnology (Healthcare). Over the past 5 years, KEEL returned 5.25%/yr vs -44.39%/yr for KPTI. At a 0.17 correlation, their price movements are largely independent.
Performance
KEEL vs. KPTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KEEL achieves a 84.68% return, which is significantly higher than KPTI's 1.49% return.
KEEL
- 1D
- 9.87%
- 1M
- -31.00%
- 6M
- 47.12%
- YTD
- 84.68%
- 1Y
- 317.31%
- 3Y*
- 35.62%
- 5Y*
- 5.25%
- 10Y*
- —
- ALL TIME*
- 14.60%
KPTI
- 1D
- -21.45%
- 1M
- -17.18%
- 6M
- 18.38%
- YTD
- 1.49%
- 1Y
- 94.03%
- 3Y*
- -33.06%
- 5Y*
- -44.39%
- 10Y*
- -23.26%
- ALL TIME*
- -24.56%
KEEL vs. KPTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
KEEL Keel Infrastructure Corporation | 84.68% | 57.72% | -48.80% | 561.36% | -91.29% | 165.79% | 397.66% | -27.96% | -64.19% |
KPTI Karyopharm Therapeutics Inc. | 1.49% | -27.45% | -21.82% | -74.56% | -47.12% | -58.46% | -19.25% | 104.59% | -48.29% |
Correlation
The correlation between KEEL and KPTI is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Aug 28, 2018 | 0.17 |
The correlation between KEEL and KPTI shifts across timeframes, from 0.09 (1 year) to 0.22 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
KEEL:
$2.62B
KPTI:
$169.29M
KEEL:
-$0.51
KPTI:
-$11.39
KEEL:
10.49
KPTI:
0.85
KEEL:
$229.28M
KPTI:
$151.12M
KEEL:
-$18.90M
KPTI:
$145.13M
KEEL:
-$149.60M
KPTI:
-$93.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KEEL vs. KPTI — Risk / Return Rank
KEEL
KPTI
KEEL vs. KPTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Keel Infrastructure Corporation (KEEL) and Karyopharm Therapeutics Inc. (KPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KEEL | KPTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.89 | ||
| Sortino ratioReturn per unit of downside risk | +1.19 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.23 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 4.34 | 1.95 | +2.39 |
| Martin ratioReturn relative to average drawdown | 7.13 | 4.87 | +2.26 |
Loading charts...
Drawdowns
KEEL vs. KPTI - Drawdown Comparison
The maximum KEEL drawdown since its inception was -95.72%, roughly equal to the maximum KPTI drawdown of -99.50%. Use the drawdown chart below to compare losses from any high point for KEEL and KPTI.
Loading charts...
Drawdown Indicators
| KEEL | KPTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.72% | -99.50% | +3.78% |
Max Drawdown (1Y)Largest decline over 1 year | -73.65% | -48.36% | -25.29% |
Max Drawdown (3Y)Largest decline over 3 years | -81.04% | -86.96% | +5.92% |
Max Drawdown (5Y)Largest decline over 5 years | -95.72% | -98.36% | +2.64% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.15% | — |
Current DrawdownCurrent decline from peak | -51.07% | -98.94% | +47.87% |
Average DrawdownAverage peak-to-trough decline | -67.17% | -75.52% | +8.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.75% | 19.38% | +25.37% |
Volatility
KEEL vs. KPTI - Volatility Comparison
Keel Infrastructure Corporation (KEEL) and Karyopharm Therapeutics Inc. (KPTI) have volatilities of 29.29% and 30.02%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KEEL | KPTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.29% | 30.02% | -0.73% |
Volatility (6M)Calculated over the trailing 6-month period | 71.73% | 65.02% | +6.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 111.13% | 95.55% | +15.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 105.29% | 95.60% | +9.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 289.41% | 86.76% | +202.65% |
Dividends
KEEL vs. KPTI - Dividend Comparison
Neither KEEL nor KPTI has paid dividends to shareholders.
Financials
KEEL vs. KPTI - Financials Comparison
This section allows you to compare key financial metrics between Keel Infrastructure Corporation and Karyopharm Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KEEL and KPTI have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KPTI has higher volatility (30.02%) compared to KEEL (29.29%). In terms of maximum drawdown, KEEL dropped -95.72% vs KPTI's -99.50%.
KEEL currently has the higher Sharpe Ratio (2.88 vs 0.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KEEL and KPTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer